Impact factor

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

Retrieved on: 
Tuesday, June 28, 2022
Factor X, Academy, The New England Journal of Medicine, Critical care, Nature Reviews Molecular Cell Biology, SSCI, Publication, Journal, Invention, Research, JCR, Technology, Clarivate, SCIE, Bya, Health and wellbeing board, Book, COVID-19, Internal medicine, Blog, Drug discovery, Sustainable development, Journal Citation Reports, Health care, Final good, Public health, UN, Policy, Infection, Literature, JIF, Journal of General Internal Medicine, List of life sciences, NYSE, Librarian, Editorial, JAMA, The Lancet, Nature Reviews Drug Discovery, Solution, Jif, Vaccine, Professional services, Impact factor, Twitter, American Medical Association, Collection, Pharmaceutical industry, Medical device, Periodical literature, Health, Lancet

LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations. The reports are used extensively by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community. 

Key Points: 
  • LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR) .
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking.
  • Key facts from the 2021 data:
    The Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries.
  • These include:
    The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.

Clarivate Names World's Leading Journals with the 2022 Journal Citation Reports

Retrieved on: 
Tuesday, June 28, 2022
Factor X, Academy, The New England Journal of Medicine, Critical care, Nature Reviews Molecular Cell Biology, SSCI, Publication, Journal, Invention, Research, JCR, Technology, Clarivate, SCIE, Bya, Health and wellbeing board, Book, COVID-19, Internal medicine, Blog, Drug discovery, Sustainable development, Journal Citation Reports, Health care, Final good, Public health, UN, Policy, Infection, Literature, JIF, Journal of General Internal Medicine, List of life sciences, NYSE, Librarian, Editorial, JAMA, The Lancet, Nature Reviews Drug Discovery, Solution, Jif, Vaccine, Professional services, Impact factor, Twitter, American Medical Association, Collection, Pharmaceutical industry, Medical device, Periodical literature, Health, Lancet

LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR)™. The annual JCR release enables the research community to evaluate the world's high-quality academic journals using a range of indicators, descriptive data and visualizations. The reports are used extensively by academic publishers across the globe to understand the scholarly impact of their journals relative to their field and promote them to the research community. 

Key Points: 
  • LONDON, June 28, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released the 2022 update to its annual Journal Citation Reports (JCR) .
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and/or citation stacking.
  • Key facts from the 2021 data:
    The Journal Citation Reports contains more than 21,000 journals, from 254 research categories and 114 countries.
  • These include:
    The Journal Citation Indicator, which represents the average category-normalized citation impact for papers published in the prior three-year period.

The Institute of Navigation selects HighWire for Hosting

Retrieved on: 
Friday, October 22, 2021
Science, HighWire, Technology, Institute of Navigation, Manuscript, Mark (given name), Partnership, JIF, General aviation, Corporation, PNT, Stanford University, ION, Impact factor, Product management, Eye, NAVIGATION, Solution, University, Institute, Journal, Surveying, Publishing

PRINCETON, N.J., Oct. 22, 2021 /PRNewswire-PRWeb/ -- The Institute of Navigation (ION) and HighWire Press are pleased to announce a three-year partnership.

Key Points: 
  • PRINCETON, N.J., Oct. 22, 2021 /PRNewswire-PRWeb/ -- The Institute of Navigation (ION) and HighWire Press are pleased to announce a three-year partnership.
  • HighWire has been selected to host NAVIGATION: Journal of the Institute of Navigation on its JCORE platform.
  • "We are so pleased to welcome ION to the HighWire and JCORE communities," commented Director of Product Management, Hosting Platforms, Olly Rickard.
  • The Institute of Navigation (ION) is a not-for-profit organization advancing Positioning, Navigation and Timing (PNT).

Enlivex CSO Prof. Dror Mevorach Publishes Foundational Paper on the Pfizer–BioNTech COVID-19 Vaccine in The New England Journal of Medicine

Retrieved on: 
Tuesday, October 12, 2021
Private Securities Litigation Reform Act, The New England Journal of Medicine, Therapy, Â, Decision-making, Pfizer–BioNTech COVID-19 vaccine, COVID-19, Animal, Clarivate, GLOBE, Marketing, Safety, Tel Aviv Sourasky Medical Center, Human, Annual report, Hebrew University of Jerusalem, U.S. Securities and Exchange Commission, Pfizer, University, Sepsis, Impact factor, Immunotherapy, Immune system, Security (finance), Hadassah Medical Center, NEJM, Patient, Risk, Research, Ministry, Nasdaq, COVID-19 vaccine, Pharmaceutical industry, Medical device

Nes-Ziona, Israel, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that its Chief Scientific Officer, Prof. Dror Mevorach, M.D., and several co-authors published a foundational peer reviewed paper in The New England Journal of Medicine, the world’s most widely read, cited, and influential general medical periodical. The paper, entitled “Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel” was published in collaboration with researchers at several prestigious institutions, including Hadassah Medical Center, University of Jerusalem, Tel Aviv Sourasky Medical Center, the Israel Center for Disease Control, and the Israeli Ministry of Health.

Key Points: 
  • On behalf of Enlivex, Id like to congratulate Dror for this impressive accomplishment, said Dr. Oren Hershkovitz, Chief Executive Officer of Enlivex.
  • Prof. Mevorach commented, It is an honor to be published in the New England Journal of Medicine, which provides our work with important external validation.
  • The New England Journal of Medicine (NEJM) is the most widely read, cited, and influential general medical periodical in the world.
  • All such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

JHLT Strengthens Impact Factor, Maintains Status as Top Journal in Transplantation for a Seventh Year

Retrieved on: 
Thursday, July 8, 2021
Publishing, Journal ranking, Publications, Academic journals, Academic publishing, Journal Citation Reports, Impact factor, Transplantation, Organ transplantation

For the seventh year in a row, JHLT's Impact Factor earned the publication number one in the transplantation category.

Key Points: 
  • For the seventh year in a row, JHLT's Impact Factor earned the publication number one in the transplantation category.
  • The Impact Factor is published in the annual Journal Citation Reports (JCR), and is determined by the number of 2020 citations accumulated for JHLT manuscripts published in the previous two years.
  • In addition to its rising Impact Factor and Immediacy Index, in 2020 the JHLT had 15,107 citations, a 21 percent increase from 2019's citation total of 12,465.
  • ISHLT is the only international interdisciplinary organization focused on interventions for advanced heart and lung disease, including transplantation.

Clarivate Releases Journal Citation Reports, Naming the World's Leading Journals

Retrieved on: 
Wednesday, June 30, 2021
Clarivate Analytics, Information science, Citation indices, Academic journals, Online databases, Publishing, Impact factor, Journal ranking, Web of Science, Academic publishing, Open Geosciences, Nursing Open

Thestructureddataarecuratedbythe global team ofexperts at Clarivate, who continuously evaluate and select the collections covered to ensureaccuracy in journal impact evaluations.

Key Points: 
  • Thestructureddataarecuratedbythe global team ofexperts at Clarivate, who continuously evaluate and select the collections covered to ensureaccuracy in journal impact evaluations.
  • More than 14,000 journals have at least one Gold Open Access publication, with more than 4,600 being fully Open Access.
  • The Journal Citation Indicator will be calculated for all journals in the Web of Science Core Collection including those that do not have a Journal Impact Factor (JIF).
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and citation stacking.

Clarivate Releases Journal Citation Reports, Naming the World's Leading Journals

Retrieved on: 
Wednesday, June 30, 2021
Clarivate Analytics, Information science, Citation indices, Academic journals, Online databases, Publishing, Impact factor, Journal ranking, Web of Science, Academic publishing, Open Geosciences, Nursing Open

Thestructureddataarecuratedbythe global team ofexperts at Clarivate, who continuously evaluate and select the collections covered to ensureaccuracy in journal impact evaluations.

Key Points: 
  • Thestructureddataarecuratedbythe global team ofexperts at Clarivate, who continuously evaluate and select the collections covered to ensureaccuracy in journal impact evaluations.
  • More than 14,000 journals have at least one Gold Open Access publication, with more than 4,600 being fully Open Access.
  • The Journal Citation Indicator will be calculated for all journals in the Web of Science Core Collection including those that do not have a Journal Impact Factor (JIF).
  • Clarivate monitors and excludes journals that demonstrate anomalous citation behavior including where there is evidence of excessive journal self-citation and citation stacking.

ACMG's Genetics in Medicine Journal Receives Impact Factor of 8.904 for 2019--Journal is Ranked 13th of 177 Journals in Genetics & Heredity

Retrieved on: 
Wednesday, July 8, 2020
Citation metrics, Impact factor, Academic journals, Publishing, Academia

This is the second highest Impact Factor in the journal's history and ranks GIM 13th of 177 titles in the Genetics & Heredity category.

Key Points: 
  • This is the second highest Impact Factor in the journal's history and ranks GIM 13th of 177 titles in the Genetics & Heredity category.
  • The Impact Factor is an objective measure of the world's leading journals, based on articles' cited references and is oft considered a measure of a journal's impact, overall successful performance and relevance to its field.
  • "GIM's editors and editorial staff are delighted that our Impact Factor has increased from last year.
  • The Impact Factor is one of a number of metrics used to evaluate journals, and a journal should not be evaluated solely on that one metric.

2019 CiteScore™ Values Released, and Improved Methodology Introduced to Provide a Faster, More Stable Indicator of Research Impact

Retrieved on: 
Tuesday, June 23, 2020
Information science, Citation metrics, Library science, CiteScore, Citation indices, Scopus, Impact factor, Percentile

In addition, an improved calculation methodology has been introduced to provide a more robust, fair and faster indicator of research impact.

Key Points: 
  • In addition, an improved calculation methodology has been introduced to provide a more robust, fair and faster indicator of research impact.
  • These include: CiteScore, CiteScore Tracker, CiteScore Percentile, CiteScore Quartiles, CiteScore Rank, Citation Count, Document Count, and Percentage Cited.
  • Calculating values for all titles included in Scopus, CiteScore covers nearly 13,000 more titles than the Impact Factor.
  • This means that all citations received by publications in this period are counted towards CiteScore values, allowing a more robust assessment.

2019 CiteScore™ Values Released, and Improved Methodology Introduced to Provide a Faster, More Stable Indicator of Research Impact

Retrieved on: 
Tuesday, June 23, 2020
Information science, Citation metrics, Library science, CiteScore, Citation indices, Scopus, Impact factor, Percentile

In addition, an improved calculation methodology has been introduced to provide a more robust, fair and faster indicator of research impact.

Key Points: 
  • In addition, an improved calculation methodology has been introduced to provide a more robust, fair and faster indicator of research impact.
  • These include: CiteScore, CiteScore Tracker, CiteScore Percentile, CiteScore Quartiles, CiteScore Rank, Citation Count, Document Count, and Percentage Cited.
  • Calculating values for all titles included in Scopus, CiteScore covers nearly 13,000 more titles than the Impact Factor.
  • This means that all citations received by publications in this period are counted towards CiteScore values, allowing a more robust assessment.